Sunday, October 18, 2026 from 2:15 p.m. to 3:45 p.m. MDT at Salt Palace Convention Center - Ballroom E
This session is being recorded.
Learn MoreAvailable for 1.50 hours of CPE creditActivity Number: 0204-9999-26-232-L01Activity Type: An Application-Based ActivityThis session aims to empower pharmacists to lead and optimize time‑sensitive care for patients presenting with spontaneous intracerebral hemorrhage (ICH). By integrating evidence-based strategies, quality metrics, and lessons from institutions using a “Code ICH” model, participants will learn how to reduce treatment delays, standardize medication-related workflows, and collaborate effectively with interprofessional teams. Closing this gap will enhance care consistency, improve adherence to national guidelines, and ultimately improve clinical outcomes in a patient population with high morbidity and mortality.
This activity is approved for Board Certified Emergency Medicine Pharmacist (BCEMP) and Board Certified Critical Care (BCCCP) recertification credit.
The BCCCP/BCEMP Clinical Sessions are part of the professional development program for the recertification of board-certified Critical Care and Emergency Medicine pharmacists by the Board of Pharmacy Specialties and jointly provided by ACCP and the American Society of Health-System Pharmacists (ASHP). In order to earn the BCCCP and/or BCEMP recertification credit, participants must attend the session, claim continuing pharmacy education credit, and pass the associated posttest(s). Access to the Clinical Session posttests will be available on December 16, 2026, at www.accp.com/myaccount to anyone who has purchased access to the BCCCP and/or BCEMP posttests. For participants who have not purchased access to the posttests, access can be purchased until 12:00 p.m. on Tuesday, October 20th, at the ACCP Registration Desk. The deadline to submit posttests for these sessions will be December 14, 2027.
Learning Objectives1. Summarize current performance and quality metrics for intracerebral hemorrhage (ICH) care.
2. Assess opportunities for rapid reversal of coagulopathies in anticoagulant-associated ICH.
3. Choose evidence-based blood pressure targets, agents, and titration strategies in acute ICH.
4. Apply time-sensitive quality metrics for the bundle of care in collaboration with the interprofessional care team.
 | | Speaker: | Casey C. May, Pharm.D., BCCCP | | Clinical Associate Professor
The Ohio State University College of Pharmacy
Columbus, Ohio | | View Biography |
|
 | | Speaker: | Andrew J. Webb, Pharm.D., BCCCP | | Clinical Pharmacy Specialist, Neurocritical Care
Massachusetts General Hospital
Boston, Massachusetts | | View Biography |
|